EN DE
Watch Israel Corp for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Israel Corp (ILCO) fair value: what the stock is really worth

As of Nov 19, 2026: fair value (intrinsic value) of Israel Corp stock ILS 43.73, price ILS 71.27, that is 38.6% below the price, quality 32 out of 100. Rating: strongly overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials Il · ISIN IL0005760173

IC Israel Corp logo Some data Nov 18, 2026

Israel Corp

ILCO · TA

Far too expensive (fair value 39% below the price), weak company and falling price: meets none of the 3 rules.

Follow free in the weekly email
Generates free cash flow 
Revenue last quarter +17% vs. a year ago. 
Thin margins · 1.6% net margin (TTM) 
Moderate debt 
Mixed vs. peers (6/14) 
Some data 
Changed on Nov 13: ILS 35.12 → ILS 42.69 
Fair value 43.73 ILS · Strongly overvalued 
Quality 32/100 
Falling price (downtrend) 
Weak Growth (revenue 3y −8.2 %/yr in USD) 
Narrow moat 37/100 · thin data
⟳ Cyclical⚠ Dilution
Watch Israel Corp for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

196.50 ILS 70.02 ILS Fair Value 43.73 ILS Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 18, 2026.

How to read this chart

60‑month range 70.02 ILS – 196.50 ILS · fair‑value band 28.55 ILS – 72.97 ILS · the 71.27 ILS price screens above the 43.73 ILS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 18, 2026.

Follow Israel in your weekly email

Every Wednesday you see whether Israel is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Israel Corporation Ltd operates in the specialty minerals and chemical businesses.

Show moreShow less

The company offers bromine and bromine-based compounds; salt, magnesium chloride, and other specialty mineral products; phosphorous based flame retardants and other phosphorus based specialty product; potash; magnesium; pure magnesium and magnesium alloys; chlorine and sylvinite; phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid; and phosphate-based fertilizers, as well as pure phosphoric acid.

It also provides controlled release fertilizers, water soluble fertilizers, liquid fertilizers and straights, FertilizerpluS, soil and foliar micronutrients, secondary nutrients, bio-stimulants, soil conditioners, seed treatment products, and adjuvants.

In addition, the company operates power plant that supplies electricity. It operates in Brazil, the United States, China, the United Kingdom, Germany, Spain, israel, France, India, Italy, and internationally. Israel Corporation ILtd was incorporated in 1968 and is based in Tel Aviv-Yafo, Israel.

Stock analysis

Israel Corp (ILCO) currently trades at 71.27 ILS, while our model-based Fair Value estimate is 43.73 ILS, 39% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 86.34 ILS per share, and 6 of the 23 models we run sit above the 71.27 ILS price.

Bear case: the Earnings-Based group reads lowest at 35.05 ILS, and 17 of the 23 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 28.55 ILS (bear) to 72.97 ILS (bull), the price of 71.27 ILS sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 32/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Israel Corp reported revenue of $7.7B in FY2025 versus $7.0B in FY2021, a compound +2.7%/yr. Reported net income was $94.2M in FY2025, compounding +1.7%/yr from FY2021.

Key figures

Market cap 5.4B ILS Small · P/E ratio 13.4 · P/S ratio 0.16 · EPS (TTM) 5.31 ILS · Dividend yield 0.8% · Net margin 1.2% · Return on equity 5.1% · Return on assets (EBIT) 11.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).

What moves the price

The share trades about 29% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −39%, ILCO screens cheaper than that median.

Fair Value models

Bear 28.55 ILS Fair Value 43.73 ILS Bull 72.97 ILS
Price 71.27 ILS · Downside -38.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 11 months old). Earnings retained since then (4.22 ILS per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income 84.33 ILS 84.76 ILS 87.39 ILS 76
EPV 25.54 ILS 32.67 ILS 38.54 ILS 73
5Y EBITDA Exit 62.71 ILS 119.46 ILS 195.45 ILS 72
All 23 models by family
DCF Models
FCF DCF 1.65 ILS 10.05 ILS 24.49 ILS 69
5Y Revenue Exit 31.57 ILS 66.05 ILS 116.92 ILS 68
5Y EBITDA Exit 62.71 ILS 119.46 ILS 195.45 ILS 72
5Y P/E Exit 8.68 ILS 26.80 ILS 48.73 ILS 65
10Y Revenue Exit 15.73 ILS 39.11 ILS 65.27 ILS 63
10Y EBITDA Exit 34.62 ILS 69.21 ILS 107.75 ILS 66
10Y P/E Exit 5.26 ILS 16.98 ILS 28.38 ILS 60
Earnings-Based
Graham-Dodd 27.22 ILS 37.42 ILS 43.50 ILS 67
EPV 25.54 ILS 32.67 ILS 38.54 ILS 73
Dividend Discount
Gordon GGM 3.01 ILS 3.25 ILS 3.58 ILS 69
DDM Multi-Stage 3.01 ILS 3.62 ILS 4.35 ILS 67
Multiples
P/E Multiple 51.04 ILS 68.05 ILS 85.07 ILS 63
P/S Multiple 51.04 ILS 68.05 ILS 85.07 ILS 57
P/B Multiple 178.79 ILS 238.39 ILS 297.99 ILS 55
EV/EBIT 55.73 ILS 91.44 ILS 127.15 ILS 63
EV/EBITDA 113.97 ILS 169.09 ILS 224.20 ILS 66
EV/Revenue 41.45 ILS 81.24 ILS 121.03 ILS 50
Asset-Based
NCAV (Graham) 39.73 ILS 53.24 ILS 79.46 ILS 53
Growth DCF
Growth DCF 2.50 ILS 10.46 ILS 23.05 ILS 69
Rev-Margin DCF 31.57 ILS 66.89 ILS 109.92 ILS 69
Economic Profit
Residual Income 84.33 ILS 84.76 ILS 87.39 ILS 76
ROIC Compounder 25.54 ILS 32.67 ILS 38.54 ILS 71
Growth Earnings
Growth-Adj P/E 36.36 ILS 51.95 ILS 67.53 ILS 67

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 32/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 26
How much profit the company makes from its sales and capital
Quality Growth 36
Are margins and returns getting better?
Cashflow 43
Do the profits arrive as real cash?
Financial strength 26
Debt, balance sheet and risk of trouble
Investment 69
Does it invest with discipline instead of growing at any price?
Low Volatility 73
How calm the share price moves, does not count
Price momentum 16
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 1
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+13.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.0%
Start year 2020 (pandemic). Over 10 years: +3.7% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.4%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−4.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−4.9%
Dividend (yield on the price)0.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−4.9% vs −11.0%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 8%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+29.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +26.7% a year for the price.

ILCO screens overvalued: fair value 39% below the price. Compare with Linde plc →

Compare Israel Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 767 stocks

Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 32 · Bottom 25%
Fair Value upside −38.6% · Below median
Profitability
Return on equity (12 months) 5.1% · Below median
Return on assets 1.7% · Below median
Net margin (12 months) 3.9% · Below median
Operating margin (12 months) 12.4% · Above median
Growth and dividend
Revenue growth (quarter YoY) 16.5% · Above median
Dividend yield (12 months) 0.8% · Below median
Balance sheet
Debt / equity 0.73× · Highest 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 13.4× · Cheaper than median
P/B 0.54× · Cheapest 25%
P/S (12 months) 0.51× · Cheapest 25%
Price / free cash flow (fiscal year) 48.5× · Priciest 25%
EV/EBITDA 5.9× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 7
FUTURE (revenue growth)83 · sector 69
PAST (return on equity)20 · sector 25
HEALTH (low debt)64 · sector 95
DIVIDEND (yield)15 · sector 31

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥69.50 ¥68.03 −2% vs ILCO
Linde plc LIN $512.16 $446.62 −13% vs ILCO
PPG Industries, Inc PPG $122.78 $77.68 −37% vs ILCO
DSM-Firmenich AG DSFIR CHF 96.85 CHF 58.32 −40% vs ILCO
Asian Paints Limited ASIANPAINT ₹2,595 ₹1,479 −43% vs ILCO
The Sherwin-Williams Company SHW $346.60 $152.59 −56% vs ILCO
Givaudan SA GIVN CHF 4,054 CHF 1,618 −60% vs ILCO
EMS-CHEMIE HOLDING AG EMSN CHF 830.50 CHF 284.63 −66% vs ILCO
Ecolab Inc ECL $300.68 $97.18 −68% vs ILCO
Air Products and Chemicals, Inc APD $308.11 $75.33 −76% vs ILCO

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Israel Corp: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Israel Corp Fair Value". https://www.fairvalue-calculator.com/stock/ILCO

Frequently asked questions

Is Israel Corp (ILCO) overvalued or undervalued?
As of Nov 18, 2026, our model estimates a fair value of 43.73 ILS versus a price of 71.27 ILS, about 39% lower (overvalued).
What is the fair value of ILCO?
Our model-based fair value for Israel Corp is 43.73 ILS (as of Nov 18, 2026), built from audited fundamentals. The current price: 71.27 ILS.
What is the quality score of ILCO?
Israel Corp has a Quality Score of 32/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Israel Corp (ILCO)?
We do not set a price target; the yardstick is the fair value of 43.73 ILS (as of Nov 18, 2026) from 23 valuation models. Cautious scenario 28.55 ILS, optimistic scenario 72.97 ILS. It is a calculation from audited fundamentals, not an analyst target.
What is the Israel Corp stock forecast for 2026?
Our models put fair value at 43.73 ILS, about 39% lower versus a price of 71.27 ILS (overvalued). Cautious scenario 28.55 ILS, optimistic scenario 72.97 ILS. The calculation is refreshed regularly with new filings.
What is the revenue of Israel Corp (ILCO)?
Israel Corp reported trailing-twelve-month revenue of about $7.7B (latest available figure, as of Nov 18, 2026).
Does Israel Corp pay a dividend?
Israel Corp currently shows a dividend yield of 0.77% relative to its recent price (as of Nov 18, 2026).
How much is the dividend of Israel Corp (ILCO) and when is the ex-dividend date?
Israel Corp pays a dividend of 0.546 ILS per share a year, a dividend yield of 0.8%. The last ex-dividend date was Apr 14, 2026. The payout ratio is 13.6% of earnings. Free cash flow covers the dividend 6.35 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Israel Corp (ILCO)?
For today's price to be fair in a discounted-cash-flow model, Israel Corp would have to grow free cash flow by 29.8 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 9.0 % per year. As of Nov 18, 2026.
What discount rate (WACC) does the fair value of ILCO use?
Our models discount Israel Corp at 11.6 %: a base by market capitalisation (small), damped by beta 0.23, country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Israel Corp that is +29.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Israel Corp (ILCO) delivered so far?
Over the past 5 years revenue at Israel Corp grew 9.0 % a year. The price currently implies free-cash-flow growth of +29.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Israel Corp (ILCO) growing?
The median revenue growth in the sector is +11.6 % a year. That is the yardstick for the growth priced into Israel Corp (+29.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Israel Corp (ILCO)?
The free-cash-flow yield on the price is 5.00 %: that much free cash flow Israel Corp produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Israel Corp (ILCO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Israel Corp it is 43.73 ILS per share (as of Nov 18, 2026), against a price of 71.27 ILS. It is the blended result of 23 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Israel Corp stock overvalued or undervalued in 2026?
As of Nov 18, 2026, ILCO trades above its calculated fair value: price 71.27 ILS, fair value 43.73 ILS, a gap of about −39% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ILCO?
No. The price is what the market pays today (71.27 ILS); the fair value is what the company's own numbers justify (43.73 ILS). For Israel Corp the two are 27.54 ILS per share apart. That gap is exactly why we show both numbers side by side.
How much is Israel Corp worth?
The market values Israel Corp at about 5.4B ILS (market capitalisation, as of Nov 18, 2026). Per share that is 71.27 ILS; our models calculate a fair value of 43.73 ILS per share.
What do the bullish and bearish scenarios say about ILCO?
Our models span a range for Israel Corp: cautious scenario 28.55 ILS, base 43.73 ILS, optimistic 72.97 ILS per share (as of Nov 18, 2026, price 71.27 ILS). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ILCO?
Israel Corp trades at a price-to-earnings ratio of 13.4 (as of Nov 18, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 43.73 ILS is built from several models across several years. Other multiples: P/B 0.5, P/S 0.5, EV/EBITDA 5.9.
How solid is the balance sheet of Israel Corp (ILCO)?
Balance-sheet figures for Israel Corp (as of Nov 18, 2026): return on equity 5.1%, debt of 0.73 per unit of equity. They feed the Quality Score of 32/100, which measures business quality independently of the share price.
How far is ILCO from its 52-week high?
Israel Corp trades at 71.27 ILS, about 29% below its 52-week high of 101.01 ILS and at the low of 71.27 ILS (as of Nov 19, 2026). Distance from the high says nothing about value: that is what the fair value of 43.73 ILS is for.
Which stocks are comparable to Israel Corp?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Israel Corp stock attractive at the current price?
The data as of Nov 18, 2026: price 71.27 ILS, calculated fair value 43.73 ILS (−39%), Quality Score 32/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ILCO calculated?
We run Israel Corp through 23 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 43.73 ILS builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.0% above its aggregate fair value. Israel Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Israel Corp (ILCO)?
The closing price on Nov 19, 2026 was 71.27 ILS. Our model-based fair value is 43.73 ILS, about 39% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Israel Corp right now?
Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (28.55 ILS to 72.97 ILS) leaves room in how you read the outcome.
Where does the earnings growth of Israel Corp (ILCO) come from?
Earnings per share at Israel Corp fell 5.0 % a year from 2014 to 2025. Broken into its drivers: revenue per share +2.8 %, EBIT margin −1.8 %, tax rate −4.9 %, residual (interest, one-offs) −1.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Israel Corp

How large is the market capitalisation of Israel Corp (ILCO)?
The market capitalisation of Israel Corp is 5.4B ILS. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Israel Corp (ILCO)?
The price-to-sales ratio of Israel Corp is 0.16 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Israel Corp (ILCO)?
Earnings per share at Israel Corp are 5.31 ILS (price ÷ EPS = P/E 13.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Israel Corp (ILCO)?
The dividend yield of Israel Corp is 0.8% (payout 10.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Israel Corp (ILCO)?
The net margin of Israel Corp is 1.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Israel Corp (ILCO)?
The return on equity (ROE) of Israel Corp is 5.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Israel Corp (ILCO)?
On an EBIT basis the return on assets of Israel Corp is 11.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Israel Corp (ILCO)?
The operating margin of Israel Corp is 12.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Israel Corp (ILCO)?
Revenue at Israel Corp is growing 16.5% versus a year earlier (3y avg −8.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Israel Corp (ILCO)?
Earnings per share at Israel Corp are growing 24.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Israel Corp (ILCO) carry?
The net debt of Israel Corp is $2.9B (fiscal year 2025, ≈ 35.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Israel Corp in the live analysis

One click puts Israel Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.